Allergan also manufactures a variety of medical products in the fields of opthamology, medical aesthetics, dermatology, neurology, and other specialty markets.
The company’s latest financials include:
- Revenues of $4,503.6 million in FY 2009
- Operating profit was $928 million in FY2009
- Net profit was $621.3 million in FY2009
A SWOT Analysis is a strategic planning tool used to evaluate:
involved in a project or in a business venture. It involves identifying the internal and external factors that are favorable and unfavorable to achieving that objective.
Taking a look at the global pharmaceutical industry, sales of prescription and over-the-counter (OTC) drugs are worth over $600 billion yearly. The US leads the world in this industry, claiming both the largest market share and five of the ten largest companies. Europe takes second place, even as the industry comes under more regulatory pressure here. Japan brings in the third place, as its super-regulated pharma industry comes out from the economic turmoil that has plagued the region.
It is a fact that pharma companies are having a tougher time in mature markets such as North America and Western Europe, whereas emerging markets such as China, India, Turkey, etc., are proving to be very promising for industry players.
It is in this industry scenario that places Allergan and carries out a SWOT analysis of the company - giving an idea about what edge the company posses over its competitors such as Abbott Laboratories, Bausch & Lomb, Pfizer, etc.
This research analyzes the company Allergan Inc in the SWOT Framework Analysis. The report includes the following:
- Business segment analysis of Allergan Inc
- Major products & services of Allergan Inc
- Profile of the industry Allergan Inc operates in
- Profile of its major competitors - Abbott Laboratories, Bausch & Lomb Incorporated, Gilead Sciences, Inc, Pfizer Inc, and ViroPharma Incorporated
- SWOT Analysis of Allergan Inc
- Future Perspective of Allergan Inc
The report Allergan Inc - SWOT Framework Analysis has a broad ranging content suitable for industry experts as well as logically initiating the industry beginners.
B. Profile of Allergan Inc
B.1 Industry Profile
B.2 Corporate Profile
B.3 Business Segment Analysis
B.4 Major Products & Services
B.5 Future Perspective: Allergan Inc
C. Competitor Profiles
C.1 Abbott Laboratories
C.1.1 Corporate Profile
C.1.2 Business Segment Analysis
C.2 Bausch & Lomb Incorporated
C.2.1 Corporate Profile
C.2.2 Business Segment Analysis
C.3 Gilead Sciences, Inc
C.3.1 Corporate Profile
C.3.2 Business Segment Analysis
C.4 Pfizer Inc
C.4.1 Corporate Profile
C.4.2 Business Segment Analysis
C.5 ViroPharma Incorporated
C.5.1 Corporate Profile
C.5.2 Business Segment Analysis
D. SWOT Framework Analysis
D.1 Strengths to Build Upon
D.2 Weaknesses to Overcome
D.3 Opportunities to Exploit
D.4 Threats to Overcome
E. Glossary of Terms